CStone Pharmaceuticals Co. Ltd. (CSPHF)
0.7547
0.00 (0.00%)
USD |
OTCM |
Oct 06, 16:00
CStone Pharmaceuticals Price to Book Value : 9.788 for Oct. 6, 2026
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| October 06, 2026 | 9.788 |
| October 05, 2026 | 9.788 |
| October 02, 2026 | 9.788 |
| October 01, 2026 | 9.788 |
| September 30, 2026 | 9.788 |
| September 29, 2026 | 8.810 |
| September 28, 2026 | 8.506 |
| September 25, 2026 | 9.337 |
| September 24, 2026 | 9.337 |
| September 23, 2026 | 9.337 |
| September 22, 2026 | 9.337 |
| September 21, 2026 | 9.337 |
| September 18, 2026 | 11.81 |
| September 17, 2026 | 11.81 |
| September 16, 2026 | 11.81 |
| September 15, 2026 | 11.81 |
| September 14, 2026 | 11.81 |
| September 11, 2026 | 11.81 |
| September 10, 2026 | 11.81 |
| September 09, 2026 | 11.81 |
| September 08, 2026 | 11.81 |
| September 04, 2026 | 11.81 |
| September 03, 2026 | 8.877 |
| September 02, 2026 | 8.877 |
| September 01, 2026 | 8.877 |
| Date | Value |
|---|---|
| August 31, 2026 | 9.079 |
| August 28, 2026 | 9.079 |
| August 27, 2026 | 9.079 |
| August 26, 2026 | 9.079 |
| August 25, 2026 | 9.079 |
| August 24, 2026 | 9.079 |
| August 21, 2026 | 9.079 |
| August 20, 2026 | 9.079 |
| August 19, 2026 | 9.079 |
| August 18, 2026 | 9.079 |
| August 17, 2026 | 9.079 |
| August 14, 2026 | 9.079 |
| August 13, 2026 | 9.079 |
| August 12, 2026 | 9.079 |
| August 11, 2026 | 9.079 |
| August 10, 2026 | 9.079 |
| August 07, 2026 | 9.209 |
| August 06, 2026 | 9.209 |
| August 05, 2026 | 9.209 |
| August 04, 2026 | 9.209 |
| August 03, 2026 | 9.209 |
| July 31, 2026 | 9.209 |
| July 30, 2026 | 9.209 |
| July 29, 2026 | 9.209 |
| July 28, 2026 | 9.209 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Ascletis Pharma, Inc. | 9.360 |
| RemeGen Co., Ltd. | 4.559 |
| InnoCare Pharma Ltd. | 2.888 |
| Adagene, Inc. | -- |
| JW (Cayman) Therapeutics Co. Ltd. | -- |
Price to Book Value Related Metrics
| PS Ratio | 18.59 |
| PEG Ratio | -0.1173 |
| Price | 0.7547 |
| Earnings Yield | -5.31% |
| Market Cap | 1.201B |
| PEGY Ratio | -0.1173 |